Table 1 Demographic and clinical data of 33 participants with schizophrenia and 29 healthy controls
Subject characteristics | Participants with schizophrenia | Healthy controls | Statistics | P value |
|---|---|---|---|---|
Male/female | 19 / 14 | 17 / 12 | χ2 = 0.01 | 0.93a |
Age (years) | 23.45 (4.05)b | 23.17 (3.05) | t = 0.31 | 0.11c |
Education (years) | 13.67 (2.12) | 14.38 (1.97) | z = − 1.38 | 0.17d |
Intracranial volume (ml) | 1647.35 (238.45) | 1645.73 (182.27) | z = − 0.15 | 0.88d |
Age at onset (years) | 19.48 (3.37) | – | ||
Duration of illness (months) | 41.27 (33.09) | – | ||
Antipsychotic dose (mg/day)e | 437.27 (268.92) | – | ||
PANSS positive score | 19.64 (4.49) | – | ||
PANSS negative score | 15.94 (4.50) | – | ||
PANSS total score | 67.79 (11.47) | – | ||